Dr Sebastian Zeki is a consultant gastroenterologist at St Thomas’ Hospital in London. His research interests include upper gastrointestinal physiology, upper gastrointestinal cancer, natural language programming and quality metrics in endoscopy. He co-leads the Gastroenterology data sciences Institute in London
PhD - Genomics of Barrett's related malignancy, 2013
University of London
Member of the Royal College of Physician, 2006
MSc Health Informatics, 2003
City University
MBBS MBChir Medicine, 2001
University College London
MA in experimental psychology, 1998
Cambridge University
Reflux can cause a number of worrying symptoms such as heartburn, regurgitation, coughs, sore throats and a hoarse voice
Feeling bloated and being gassy can be embarrassing but is usually avoidable with careful investigation and personalised treatment
Daycase endoscopic removal using mucosal and submucosal dissection
The increasingly common condition called eosinophilic oesophagitis and its relationship to food
The feeling of food getting stuck after swallowing, or choking can be due to a number of different problems from obstructions, to weak or even overactive oesophageal muscles
Dietary intervention is effective for the management of eosinophilic oesophagitis (EoE) in both adults and children. The majority of research has been conducted in Spain or the United States, with no studies of dietary intervention published in the United Kingdom. Restrictive elimination diets can be challenging…….
Medical data is increasingly kept in an electronic format worldwide (Bretthauer M. 2016).This serves many purposes including more efficient storage, distribution and accessibility of patient-focussed data. As important is the ability to analyse healthcare data for to optimize resource deployment and usage……
Barretts oesophagus represents the most significant risk factor for the development of oesophageal adenocarcinoma (OAC), although the majority of patients will not develop cancer. However, early detection of OAC……
Radiofrequency ablation (RFA) is used to successfully eliminate Barrett’s esophagus (BE)-related dysplasia or intramucosal carcinoma and aims to cause reversion to squamous epithelium. However, in 20% of cases RFA fails to return……